Greenwich LifeSciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:GLSI Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
21 Nov 24	BuyUS$12,910	Jaye Thompson	Individual	1,000	US$12.91
26 Sep 24	BuyUS$21,945	Snehal Patel	Individual	1,500	US$14.63
12 Aug 24	BuyUS$11,080	Jaye Thompson	Individual	800	US$13.85
06 Aug 24	BuyUS$27,620	Snehal Patel	Individual	2,000	US$13.81
05 Aug 24	BuyUS$72,490	Snehal Patel	Individual	5,500	US$13.18
02 Aug 24	BuyUS$15,150	Jaye Thompson	Individual	1,000	US$15.15
23 Jul 24	BuyUS$23,835	Snehal Patel	Individual	1,500	US$15.89
18 Jul 24	BuyUS$16,000	Jaye Thompson	Individual	1,000	US$16.00
13 Jun 24	BuyUS$2,499,998	Snehal Patel	Individual	174,825	US$14.30
01 Apr 24	BuyUS$57,240	Snehal Patel	Individual	3,000	US$19.08
22 Mar 24	BuyUS$49,950	Snehal Patel	Individual	2,500	US$19.98
20 Mar 24	BuyUS$26,520	Snehal Patel	Individual	1,500	US$17.68
05 Mar 24	BuyUS$43,715	Snehal Patel	Individual	3,500	US$12.49
04 Mar 24	BuyUS$53,423	Snehal Patel	Individual	4,100	US$13.03
16 Feb 24	BuyUS$120,528	Snehal Patel	Individual	10,800	US$11.16
15 Feb 24	BuyUS$140,589	Snehal Patel	Individual	12,700	US$11.07

Insider Trading Volume

Insider Buying: GLSI insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GLSI?
Owner Type	Number of Shares	Ownership Percentage
Institutions	1,239,327	9.43%
General Public	4,684,028	35.6%
Individual Insiders	7,221,298	54.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.3%.

Top Shareholders

Top 25 shareholders own 64.16% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
42.1%	Snehal Patel	5,536,102	US$69.3m	0%	no data
4.72%	David McWilliams	620,327	US$7.8m	0%	no data
3.02%	Kenneth Hallock	397,333	US$5.0m	0%	no data
2.66%	BlackRock, Inc.	350,144	US$4.4m	13.4%	no data
2.38%	Eric Rothe	313,255	US$3.9m	0%	no data
2.08%	The Vanguard Group, Inc.	273,525	US$3.4m	2%	no data
2.01%	Jaye Thompson	264,148	US$3.3m	0.38%	no data
1.02%	Geode Capital Management, LLC	133,550	US$1.7m	4.59%	no data
0.69%	Frank Daugherty	90,133	US$1.1m	0%	no data
0.66%	Degroof Petercam Asset Management	87,000	US$1.1m	0%	0.01%
0.66%	DIMlux S.A.	87,000	US$1.1m	0%	1.44%
0.57%	Northern Trust Global Investments	74,500	US$932.7k	206%	no data
0.54%	State Street Global Advisors, Inc.	71,408	US$894.0k	4.39%	no data
0.25%	Renaissance Technologies LLC	32,500	US$406.9k	-11.9%	no data
0.13%	Morgan Stanley, Investment Banking and Brokerage Investments	17,031	US$213.2k	141%	no data
0.13%	Charles Schwab Investment Management, Inc.	16,455	US$206.0k	-10.8%	no data
0.097%	STRS Ohio	12,800	US$160.3k	167%	no data
0.085%	BNY Asset Management	11,203	US$140.3k	-26.8%	no data
0.081%	Millennium Management LLC	10,638	US$133.2k	0%	no data
0.065%	Barclays PLC Private Banking & Investment Banking Investment	8,560	US$107.2k	323%	no data
0.048%	Rhumbline Advisers Ltd Partnership	6,302	US$78.9k	-7.31%	no data
0.046%	New York State Common Retirement Fund	6,000	US$75.1k	0%	no data
0.045%	Bank of America Corporation, Asset Management Arm	5,940	US$74.4k	-6.13%	no data
0.033%	Citigroup Inc.,Banking and Securities Investments	4,308	US$53.9k	232%	no data
0.025%	Mirae Asset Global Investments Co., Ltd.	3,330	US$41.7k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 00:27
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Greenwich LifeSciences, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yi Chen	H.C. Wainwright & Co.